Project Firstline conversation Friday related to COVID-19 outpatient therapeutics
Join AHA and the Centers for Disease Control and Prevention Friday at 2 p.m. ET for a Project Firstline conversation on caring safely for COVID-19 patients. Michael Bell, M.D., deputy director of CDC’s Division of Health Care Quality Promotion, will share the latest information on COVID-19 therapeutics available through outpatient centers and answer questions. Register here. AHA is a national partner in CDC’s Project Firstline, a national training collaborative to help health care and public health personnel prevent the spread of COVID-19 infections and protect their health.
Related News Articles
Blog
The RAND Corporation recently released the fifth iteration of its biannual hospital price report. The AHA has previously highlighted significant flaws with…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…